October 2011 Monthly Health Impact Report

Transcription

1 HEALTH IMPACT REPORT October Monthly Health Impact Report OCTOBER, PSI AVERTED AN ESTIMATED 17,899,945 DALYs (88% of the strategic target, the goal is 80%). This is a 66% increase from. Oct. 11 DALYs averted include: 17,824,617 product and service DALYs, almost half (47%) were from malaria net distribution campaigns in 10 countries: Angola, Burundi, Cameroon, Congo Kinshasa, Cote d Ivoire, Kenya, Malawi, Mali, Mozambique, and Zambia. 75,328 BCC DALYs averted in 16 countries (for specific behavior change behind the impact see page 8 of the executive summary or Oct. 11 incomplete data: ~40,000 DALYs were missing due to a Lawson reporting issue in South Africa. 15,020,688 CYPs, a 1% increase from Oct. 10, see page 5 of the executive summary for more details. BURDEN OF DISEASE PSI averted an estimated 1.02% of national burden of disease PSI addressed an estimated 26.0% of national burden of disease (relevance), for a complete list see page 9 of the executive summary PSI STRATEGIC PERFORMANCE: 2006 to OCTOBER Million DALYs 24 20,253, ,441,550 18,227,802 17,899, ,504,254 16,202,491 16,172, ,151,868 12,061,992 14,177,180 10,786,674 10,126,557 9,338,494 11,841,323 10,126, ,240,974 7,547,115 4 Strategic Target Performance Year End Performance This report was produced with the version DALY translation models OCTOBER HEALTH IMPACT REPORT EXECUTIVE SUMMARY 1

2 s AVERTED BY REGION & HEALTH AREA (% FROM PRIOR YEAR) All regions except LAC experienced an increase in DALYs averted relative to October. Million DALYs East Africa 18% 53% 17% 9% Child Survival Malaria Control Reproductive Health HIV & TB East Africa: increase in :: malaria net distribution in Burundi, Kenya, Mozambique, Malawi and Angola :: free condom distribution in Kenya and Uganda :: malaria ACT (PPT) and pneumonia PPT distribution in Malawi :: basic care package distribution in Uganda and Ethiopia Million DALYs Southern Africa 21% 13% 2% 16% Child Survival Malaria Control Reproductive Health HIV & TB Southern Africa: increase in :: malaria net distribution in Zambia :: condom distribution in Zimbabwe, Zambia and Lesotho :: male circumcision in Zimbabwe and Zambia :: free condom distribution in Botswana, Madagascar and Lesotho :: ORS distribution in Zimbabwe :: SWS and 3month injectable in Madagascar Million DALYs West & Central Africa 196% 111% 23% 9% Child Survival Malaria Control Reproductive Health HIV & TB West & Central Africa: increase in :: malaria net distribution in CongoKinshasa, Cote d'ivoire, Mali, Nigeria, and Cameroon :: 3month injectable distribution in Nigeria and CongoK :: malaria ACT (PPT) distribution in Nigeria and Mali :: pneumonia PPT distribution in CongoK :: malaria RDK and free condom distribution in Nigeria Million DALYs Asia and Eastern Europe 13% 26% 2% 2% Child Survival Malaria Control Reproductive Health HIV & TB Asia and Eastern Europe: increase in :: condom distribution in India, Pakistan, Papua New Guinea, and Laos :: malaria RDK, retreatment KO 123, TB DOTS, and ACT (PPT) distribution in Myanmar :: OC distribution in Pakistan and Cambodia :: iron folate tablet and IUD distribution in India :: free condom distribution in Cambodia Thousand DALYs Latin America & the Caribbean 12% 8% 13% 6% Child Survival Malaria Control Reproductive Health HIV & TB Latin America and Caribbean: decrease in :: ORS distribution in Haiti :: free condom distribution in Honduras :: condom distribution in Dominican Republic, Guatemala, El Salvador, and Nicaragua :: IUD insertion in Nicaragua and Guatemala :: multivitamin distribution in Paraguay Note: countries listed by the magnitude of DALYs averted OCTOBER HEALTH IMPACT REPORT EXECUTIVE SUMMARY 2

3 s AVERTED BY HEALTH AREA & REGION (% FROM PRIOR YEAR) October DALYs averted from all health areas increased relative to October, except HIV. Million DALYs HIV & TB 7% 12% 6% 7% Latin America & Caribbean Asia & Eastern Europe West & Central Africa Southern Africa East Africa HIV & TB: decrease in :: free condom distribution in South Africa, Zimbabwe, Tanzania, CongoK, and Mozambique :: basic care package distribution in Kenya and Mozambique :: condom distribution in Mozambique, Tanzania, CongoK, Kenya, South Africa, and Cote d'ivoire (AIMAS) :: adult male circumcision in Swaziland :: VCT service in Nigeria and Swaziland Million DALYs Reproductive Health 12% 4% 12% 10% Latin America & Caribbean Asia & Eastern Europe West & Central Africa Southern Africa East Africa Reproductive Health: increase in :: free condom distribution in Kenya :: condom distribution in India, Nigeria, Pakistan, and Zambia :: 3month injectable distribution in Nigeria, CongoK, and Madagascar :: OC distribution in Pakistan and Cote d'ivoire (AIMAS) :: iron folic acid tablet distribution in India Million DALYs Malaria Control 164% 138% 6% 30% Latin America & Caribbean Asia & Eastern Europe West & Central Africa Southern Africa East Africa Malaria Control: increase in :: malaria net distribution in CongoK, Cote d'ivoire, Mali, Zambia, Burundi, Nigeria, Kenya, Cameroon, Mozambique, Malawi, and Angola :: malaria ACT (PPT) distribution in Malawi, Nigeria, and Mali :: malaria RDK distribution in Myanmar and Nigeria Million DALYs Child Survival 22% 16% 7% 19% Latin America & Caribbean Asia & Eastern Europe West & Central Africa Southern Africa East Africa Child Survival: increase in :: pneumonia PPT distribution in Malawi and CongoK :: ORS distribution in Cote d'ivoire and Zimbabwe :: safe water solution distribution in Madagascar and Nigeria :: diarrhea treatment kit distribution in Myanmar :: sprinkles distribution in Pakistan Note: countries listed by the magnitude of DALYs averted OCTOBER HEALTH IMPACT REPORT EXECUTIVE SUMMARY 3

4 DALYs AVERTED FROM PRODUCTS AND SERVICES DISTRIBUTED FOR FREE 62% of PSI's DALYs are from free products. Malaria nets (LLINs) account for 78% of all free product DALYs % 62% 66% LLIN 10 57% Malaria PPT (ACT) Basic Care Package Million DALYs % 20% 27% 48% Annualized Pneumonia PPT KO123 with net ITN KO123 VCT TBDOTS IconMaxx Safe Water Solution Male Circumcision IUD Distribution Implant 5 Dist. VSC Other Free Products Note: Assuming 25% of all family planning insertion services are free of charge S IN PRODUCT AND SERVICE DALYs AVERTED (absolute change from prior ) :: Sexual, Reproductive Health and TB 3 month injectable DALYs up (Nigeria, Congo K, and Madagascar), adult MC DALYs up (Zimbabwe and Zambia), iron folate tablet DALYs up (India) Free condom DALYs down (South Africa, Zimbabwe, and Tanzania), VSC DALYs down (Pakistan), VCT DALYs down (Nigeria, Swaziland, and Zimbabwe) 30,000 25,000 20,000 65,587 24,628 21,600 15,000 10,000 10,911 10,685 5,000 5,654 5,446 4,845 4,055 3,664 2,988 2, (102) (182) (222) (664) (1,410) (3,297) (3,908) (9,735) (1,295) (3,241) (3,601) (7,676) (37,029) (36,513) (153,476) (5,000) (10,000) :: Malaria and Child Survival LLIN DALYs up (Congo K, Cote d'ivoire, Mali, Zambia, Burundi, Nigeria, Kenya, Cameroon, Mozambique, Malawi, and Angola), ACT DALYs up (Malawi) Retreatment KO123 with ITN and KO 123 kit DALYs down (Tanzania and Kenya), malaria ACT PPT DALYs down (South Sudan, Rwanda, and Madagascar) 7,490,010 79,015 50,000 45,753 40,000 30,000 20,000 10,000 4,472 2,406 1,772 1,230 (1,464) (4,989) (9,228) (18,844) (39,459) (43,618) (92,520) (227,325) (10,000) OCTOBER HEALTH IMPACT REPORT EXECUTIVE SUMMARY 4

5 CYPs, CASES AVERTED, AND DEATHS AVERTED October West & Central Africa East Africa Southern Africa Latin America & the Caribbean Asia & Eastern Europe PSI GLOBAL HIV & TB :: HIV Cases Averted 47,519 32,936 52, , ,296 :: IDU Overdose Deaths Averted :: STI Deaths Averted :: TB Deaths Averted 1,780 1,780 Reproductive Health :: CYPs* 4,309,241 2,224,000 2,486, ,399 5,447,427 15,020,688 :: Maternal Deaths Averted 9,049 3,157 2, ,243 18,799 :: Unintended Pregnancies Averted 1,345, , ,569 95, ,608 3,478,878 Malaria Control :: Malaria Cases Averted 25,186,995 15,521,369 2,236,528 5, ,309 43,124,305 :: Malaria Deaths Averted 226, ,673 24, , ,530 Child Survival :: Diarrhea Cases Averted 416,960 1,446,322 1,207,498 18,092 98,597 3,187,469 :: Diarrhea Deaths Averted 1,760 2,954 2, ,498 8,883 :: Nutrition Deaths Averted :: Pneumonia Deaths Averted 685 2, ,718 * Using USAID conversion factors CYPs BY METHOD (% FROM PRIOR YEAR) The largest increase between Oct and Oct was from sold condoms in India and Pakistan, free condom distribution in Kenya, OC distribution in Pakistan and 3 month injectable distribution in Nigeria. Million CYPs % % 19% Growth in CYPs by Product: 2000 to Annualized % Change over the prior year VFT 5% 8% 6% 5% 3% 14% 14% 15% 1% Comparison 1% 0 Free Female Implant 3 Insertion Implant 3 Distribution Injectable 1 Female Cycle Beads Implant 5 Insertion Implant 5 Distribution Emergency Contraception VSC Injectable 2 Free Injectable 3 IUD Insertion IUD Distribution OC Note: using USAID conversion factors OCTOBER HEALTH IMPACT REPORT EXECUTIVE SUMMARY 5

6 PRODUCT, SERVICE and BCC DALYS AVERTED Sexual, Reproductive Health, and TB Malaria and Child Survival Product & Service '11 DALYs Absolute Change vs '10 % Change vs '10 3,436,070 (7,676) 0% 1) LLIN* 10,308,510 Free 715,280 (153,476) 18% 2) 3,436,070 OC 394,071 5,446 1% 3) Malaria PPT (ACT) 1,032,902 Injectable 3 258,800 65,587 34% 4) Free 715,280 Basic Care Package* 230,043 (1,295) 1% 5) OC 394,071 IUD Distribution* 213,787 (9,735) 4% 6) Injectable 3 258,800 VCT* 122,694 (36,513) 23% 7) Basic Care Package* 230,043 Male Circumcision* 113,340 24,628 28% 8) IUD Distribution* 213,787 IUD Insertion* 84,964 4,845 6% 9) Safe Water Solution 148,525 BCC (HIV)* 75,328 16,221 27% 10) VCT* 122,694 TB DOTS 52,978 10,685 25% 11) Pneumonia PPT 114,705 Implant 5 Insertion* 51,884 2,525 5% 12) Male Circumcision* 113,340 Injectable 2 50,621 (3,908) 7% 13) IUD Insertion* 84,964 Iron Folic Acid Tablet 50,149 21,600 76% 14) Malaria RDK 84,215 Female 37,753 10,911 41% 15) BCC (HIV)* 75,328 STI Kit 23,477 5,654 32% 16) ORS 66,241 Misoprostol 20,282 (3,297) 14% 17) TB DOTS 52,978 Emergency Contraception 20,086 3,664 22% 18) Implant 5 Insertion* 51,884 Cycle Beads (SDM)* 15,889 (3,601) 18% 19) Injectable 2 50,621 Implant 5 Distribution* 15, % 20) Iron Folic Acid Tablet 50,149 Medication Abortion 9,194 4,055 79% 21) Diarrhea Treatment Kit 42,798 VSC* 9,009 (37,029) 80% 22) Female 37,753 Multivitamin 6, % 23) STI Kit 23,477 Implant 3 Insertion* 4,157 2, % 24) Misoprostol 20,282 No. s Ranked by Product & Service Needle & Syringe 3,485 (182) 5% 25) Emergency Contraception 20,086 Naloxone 2,448 (222) 8% 26) Water Treatment Tablet 17,534 Free Female 2,428 (664) 21% 27) Cycle Beads (SDM)* 15,889 Clean Delivery Kit 2,042 (102) 5% 28) Implant 5 Distribution* 15,879 Injectable 1 1,929 (1,410) 42% 29) Retreatment KO123* 13,278 Early Infant MC* 1,308 1,308 NA 30) Medication Abortion 9,194 ARV Prophylaxis 28 wks 1,236 1,236 NA 31) VSC* 9,009 Nevirapine NA 32) Retreatment 8,832 HAART NA 33) ITN* 8,282 Manual Vacuum Aspiration % 34) Retreatment IconMaxx* 7,796 Implant 3 Distribution* (1,804) (3,241) 226% 35) KO123 bundled with net* 7,704 LLIN* 10,308,510 7,490, % 36) Multivitamin 6,279 Malaria PPT (ACT) 1,032,902 (92,520) 8% 37) PUR 5,644 Safe Water Solution 148,525 4,472 3% 38) Sprinkles 4,639 Pneumonia PPT 114,705 79, % 39) Implant 3 Insertion* 4,157 Malaria RDK 84,215 45, % 40) Needle & Syringe 3,485 ORS 66,241 1,772 3% 41) Naloxone 2,448 Diarrhea Treatment Kit 42,798 (9,228) 18% 42) Free Female 2,428 Water Treatment Tablet 17,534 (4,989) 22% 43) Clean Delivery Kit 2,042 Retreatment KO123* 13,278 (43,618) 77% 44) Injectable 1 1,929 Retreatment 8,832 (5,040) 36% 45) Zinc 1,482 ITN* 8,282 (39,459) 83% 46) Early Infant MC* 1,308 Retreatment IconMaxx* 7,796 (18,844) 71% 47) ARV Prophylaxis 28 wks 1,236 KO123 bundled with net* 7,704 (227,325) 97% 48) Nevirapine 859 PUR 5,644 1,230 28% 49) HAART 859 Sprinkles 4,639 2, % 50) Manual Vacuum Aspiration 50 Zinc 1,482 (1,464) 50% 51) Implant 3 Distribution* (1,804) * Multi year protection product OCTOBER HEALTH IMPACT REPORT EXECUTIVE SUMMARY 6

7 COUNTRY DALYS AVERTED Latin America and Caribbean Southern Africa East Africa West and Central Africa Asia and Eastern Europe Country '11 DALYs Absolute Change vs '10 % Change vs '10 No. s Ranked by Country Congo Kinshasa 2,987,650 2,609, % 1) Congo Kinshasa 2,987,650 Nigeria 2,400, ,253 36% 2) Nigeria 2,400,745 Cote d'ivoire 1,776,835 1,768, % 3) Cote d'ivoire 1,776,835 Mali 1,188, , % 4) Kenya 1,557,479 Cameroon 526, , % 5) Mali 1,188,908 Cote d'ivoire (AIMAS) 135,394 (16,098) 11% 6) Zambia 1,051,834 Benin 92,156 (6,235) 6% 7) Burundi 794,126 Burkina Faso 78,023 2,457 3% 8) Malawi 640,247 Togo 54,387 (2,808) 5% 9) Mozambique 580,408 Guinea 39,759 (11,019) 22% 10) South Africa 550,095 C.A.R. 23,855 (1,154) 5% 11) Cameroon 526,423 Liberia 4,570 2, % 12) India 447,326 Kenya 1,557, ,024 46% 13) Angola 433,632 Burundi 794, , % 14) Tanzania 394,595 Malawi 640, , % 15) South Sudan 304,693 Mozambique 580, ,709 54% 16) Zimbabwe 285,272 Angola 433, ,153 70% 17) Pakistan 264,582 Tanzania 394,595 (311,209) 44% 18) Madagascar 250,493 South Sudan 304,693 (915,113) 75% 19) Myanmar 216,374 Uganda 178,773 28,733 19% 20) Uganda 178,773 Ethiopia 83,083 16,922 26% 21) Cote d'ivoire (AIMAS) 135,394 Rwanda 80,382 (258,139) 76% 22) Benin 92,156 Somaliland 4,852 (2,373) 33% 23) Lesotho 90,323 Zambia 1,051, , % 24) Cambodia 86,591 South Africa 550,095 (314,339) 36% 25) Ethiopia 83,083 Zimbabwe 285,272 6,339 2% 26) Rwanda 80,382 Madagascar 250,493 35,563 17% 27) Burkina Faso 78,023 Lesotho 90,323 30,341 51% 28) Togo 54,387 Botswana 53,134 21,313 67% 29) Botswana 53,134 Swaziland 49,988 (32,270) 39% 30) Swaziland 49,988 Namibia 12,147 (10,294) 46% 31) Guinea 39,759 Haiti 12,016 1,060 10% 32) C.A.R. 23,855 Guatemala 10,624 (728) 6% 33) Nepal 14,616 Dominican Republic 9,249 (871) 9% 34) Namibia 12,147 Paraguay 4,654 (457) 9% 35) Haiti 12,016 Nicaragua 4,566 (420) 8% 36) Papua New Guinea 10,630 El Salvador 3,154 (380) 11% 37) Guatemala 10,624 Honduras 2,905 (1,482) 34% 38) Vietnam 9,676 Panama 1, % 39) Dominican Republic 9,249 Belize % 40) Laos 7,277 Caribbean % 41) Romania 4,923 Costa Rica 310 (20) 6% 42) Somaliland 4,852 Mexico % 43) Paraguay 4,654 Cambodia 86,591 (3,899) 4% 44) Liberia 4,570 China % 45) Nicaragua 4,566 India 447,326 96,292 27% 46) El Salvador 3,154 Kazakhstan 1,519 (785) 34% 47) Honduras 2,905 Kyrgyzstan 132 (268) 67% 48) Russia 2,655 Laos 7,277 3, % 49) Thailand 2,092 Myanmar 216,374 53,774 33% 50) Panama 1,867 Nepal 14, % 51) Kazakhstan 1,519 Pakistan 264,582 (36,906) 12% 52) Tajikistan 1,136 Papua New Guinea 10,630 9, % 53) China 596 Romania 4,923 2, % 54) Belize 364 Russia 2,655 (277) 9% 55) Caribbean 323 Tajikistan 1, % 56) Costa Rica 310 Thailand 2, % 57) Mexico 196 Vietnam 9,676 (891) 8% 58) Kyrgyzstan 132 OCTOBER HEALTH IMPACT REPORT EXECUTIVE SUMMARY 7

8 DALYS AVERTED BY PSI's BCC PROGRAMS THROUGH OCTOBER No. Region Country Behavior that changed over time TRaC1 and TRaC2 dates BCC DALYs averted through October Credit Period* Anniversary BCC DALYs averted October 1 WCA Burkina Faso 2 WCA Cote d'ivoire use by general population with non cohabitating partners use by soldiers with all types of partners Jan 2006 Jan 238 Jan 2006 Jan 48 Mar 2008 Mar 8,483 Mar 2008 to Mar 2,828 3 WCA Togo use by FSW with clients Feb 2005 Feb ,368 Feb 2005 Feb EA Burundi 5 EA Kenya 6 EA Malawi 7 SA South Africa 8 LAC Dominican Republic 9 LAC El Salvador 10 LAC Honduras 11 LAC Nicaragua 12 LAC Nicaragua 13 Asia/EE Cambodia use by youth with nonmarital partners use among male youth with casual partners use by youth with nonmarital partners Number of casual partners among youth use by Bateyes (migrant workers) with sex workers use by MSM with steady partners use by MSM with steady partners use by FSW with all types of partners use by MSM with all types of partners use by high risk urban men with sweethearts Jun 2006 Feb ,812 Jun 2006 to Feb 1,674 Oct 2005 Oct Oct 2005 Oct Jul 2005 Jul ,332 Jul 2005 Jul 722 Dec 2006 Dec Dec 2006 Dec Mar 2006 Jul ,152 Mar 2006 Jul 216 Sep 2007 Aug ,776 Sep 2007 Aug 453 Sep 2007 Aug ,178 Sep 2007 Aug 556 Feb 2005 Nov ,453 Feb 2005 Nov Feb 2005 Nov ,371 Feb 2005 Nov Jun 2008** Jan ,369 Jun 2008 Jan Asia/EE India use by clients of FSW Apr 2006 Feb ,433 Apr 2006 Feb 7, Asia/EE Laos use by FSW with clients Dec 2005 Apr Dec 2005 Apr 0 16 Asia/EE Russia use by MSM with MSW Oct 2006 Oct Oct Oct Asia&EE Russia use by FSW with clients May 2009 Mar 12 May 2009 Mar 18 Asia&EE Thailand use by transgenders with paying partners Jun 2006 Jul Jun 2006 to Jul 56 Total DALYs averted by PSI's BCC Programs through October 75,328 14,219 * Note: BCC DALYs are calculated from data from the second round TRaC (or mid or endline TRaC) and credited for the years between the first and second round TRaCs. BCC effectiveness is presumed to continue for three years after this initial calculation. These additional "continued effectiveness" (or "anniversary") DALYs are credited each year for three years on the anniversary of the first calculation. ** Start date of the Cambodian program (not the date of TRaC1) OCTOBER HEALTH IMPACT REPORT EXECUTIVE SUMMARY 8

9 October PSI Platform Relevance and Impact National Burden of Disease (WHO 2004) Oct. '11 National Burden of Disease Averted by PSI Platform Country BOD Addressed by PSI Platform (Relevance) % of National BOD Number of DALYs BOD All PSI Health Areas* Number of DALYs BOD All Causes Number of DALYs % of National BOD Averted Number of DALYs Averted Zimbabwe 66.2% 5,862,610 6,625,592 8,851, % 224,098 Lesotho 65.7% 531, , , % 87,088 Malawi 65.1% 4,932,253 5,491,549 7,574, % 424,042 Botswana 60.6% 541, , , % 53,134 Uganda 59.1% 8,357,128 9,378,818 14,145, % 148,673 Namibia 58.4% 350, , , % 11,100 Swaziland 57.9% 327, , , % 31,059 Zambia 57.4% 4,043,780 5,102,709 7,043, % 480,960 Congo Kinshasa 56.8% 21,178, ,221, ,312, % 1,214,868 Mozambique 52.0% 5,019,197 6,527,762 9,655, % 282,286 Kenya 51.2% 7,534,325 9,773,633 14,720, % 829,032 Tanzania 47.8% 8,691,734 11,641,534 18,189, % 375,548 Cameroon 45.7% 3,642,264 4,842,786 7,969, % 253,364 South Africa 45.6% 9,573,281 12,269,160 20,988, % 533,918 Rwanda 44.2% 2,389,568 3,717,293 5,404, % 79,475 Benin 41.8% 1,477,478 2,127,594 3,530, % 75,064 Cote d'ivoire 41.3% 4,591,033 6,228,149 11,110, % 621,912 Mali 41.3% 2,916,331 4,679,190 7,065, % 515, Burundi 41.0% 1,880,285 2,951,738 4,587, % 286,789 Nigeria 40.5% 31,433,187 44,723,702 77,690, % 1,958,189 Ethiopia 40.3% 14,744,879 23,237,032 36,594, % 81,039 Angola 37.8% 4,719,172 7,979,697 12,469, % 183,824 Togo 37.2% 945,924 1,553,230 2,539, % 45,526 Myanmar 34.0% 4,666,730 5,111,490 13,710, % 203,320 Madagascar 32.0% 2,071,023 3,467,353 6,466, % 233,945 Pakistan 31.3% 12,686,028 16,744,895 40,560, % 191,073 Liberia 31.2% 733,816 1,454,888 2,352, % 4,570 Cambodia 29.8% 1,490,858 2,605,691 5,002, % 78,448 C.A.R. 28.3% 642,603 1,327,592 2,273, % 23,855 Guinea 27.9% 1,095,787 2,315,340 3,929, % 39,475 Sudan 27.7% 3,885,989 5,705,854 14,016, % 254,430 Cote d'ivoire (AIMAS) 27.1% 3,009,857 6,228,149 11,110, % 135,394 Haiti 26.8% 906,277 1,533,020 3,377, % 11,721 Nepal 22.3% 1,749,167 2,991,031 7,837, % 5,322 India 22.3% 67,982, ,428, ,111, % 418,978 Tajikistan 19.5% 315, , ,616, % 03% 439 Dominican Republic 19.3% 383, ,739 1,986, % 9,465 Honduras 18.7% 250, ,852 1,341, % 2,349 Guatemala 18.6% 509, ,244 2,730, % 8,499 Papua New Guinea 16.8% 286, ,774 1,699, % 10,630 Thailand 16.5% 2,114,916 3,187,525 12,841, % 2,148 Belize 15.4% 8,301 12,573 53, % 364 Burkina Faso 15.3% 1,135,507 4,699,847 7,402, % 77,976 Laos 14.9% 242, ,736 1,627, % 7,263 Caribbean 13.5% 126, , , % 03% 323 Panama 13.1% 61, , , % 1,867 Vietnam 13.0% 1,672,983 3,088,427 12,849, % 9,676 Nicaragua 12.6% 118, , , % 2,584 Kyrgyzstan 12.3% 146, ,576 1,188, % 132 Paraguay 12.2% 118, , , % 4,654 El Salvador 11.7% 144, ,942 1,240, % 2,780 Kazakhstan 9.9% 411, ,765 4,166, % 367 Mexico 9.3% 1,417,399 2,494,795 15,192, % 196 China 6.7% 13,452, ,865, ,524, % 00% 590 Costa Rica 5.8% 30,724 54, , % 310 Russia 2.7% 1,072,160 3,224,578 40,347, % 2,719 Romania 2.3% 87, ,180 3,842, % 4,923 PSI Global 26.0% 267,702, ,141,471 1,029,459, % 10,547,352 *PSI current interventions includes HIV/AIDS, STIs excluding HIV, Tuberculosis, Diarrheal diseases, Malaria, Respiratory infections, Maternal & Perinatal conditions, and Nutritional deficiencies OCTOBER HEALTH IMPACT REPORT EXECUTIVE SUMMARY 9

10 October PSI Platform Relevance and Impact BOD Addressed by PSI Platf form (Relev vance) 70.0% 60.0% 50.0% 40.0% Liberia 30.0% 0% Haiti Nepal 20.0% Thailand 10.0% Uganda Namibia Zimbabwe Congo Kinshasa Mozambique Malawi Botswana Swaziland Kenya Tanzania South Africa Cameroon Rwanda Cote d'ivoire Ethiopia Benin Nigeria Angola Burundi Togo Pakistan Myanmar Madagascar CAR C.A.R. Cambodia Sudan Cote d'ivoire (AIMAS) India Dominican Republic Papua New Guinea Burkina Faso Paraguay Mexico Costa Rica Zambia Mali Lesotho >= 50% Relevance 40% to 49% Relevance 30% 39% Relevance 20% to 29% Relevance < 20% Relevance Romania 0.0% 0% 2% 4% 6% 8% 10% 12% National BOD Averted OCTOBER HEALTH IMPACT REPORT EXECUTIVE SUMMARY 10

11 :: PSI Country Programs West and Central Africa Benin Burkina Faso C.A.R. Cameroon Congo Kinshasa Cote d Ivoire Cote d Ivoire (AIMAS) Guinea Liberia Mali Nigeria Togo East Africa Angola Burundi Ethiopia Kenya Malawi Mozambique Rwanda Somaliland South Sudan Tanzania Uganda Southern Africa Botswana Lesotho Madagascar Namibia South Africa Swaziland Zambia Zimbabwe Latin America and the Caribbean Central America Belize Costa Rica El Salvador Guatemala Honduras Nicaragua Panama Caribbean Antigua Barbados Dominica Grenada Jamaica St. Kitts St. Lucia St. Martin St. Vincent Suriname Trinidad Other LAC countries Dominican Republic Haiti Mexico Paraguay Asia and Eastern Europe Asia Cambodia China India Kazakhstan Kyrgyzstan Laos Myanmar Nepal Pakistan Papua New Guinea Thailand Tajikistan Vietnam Eastern Europe Romania Russia OCTOBER HEALTH IMPACT REPORT EXECUTIVE SUMMARY 11

12 :: Products & Services by Health Area HIV & TB Antiretroviral Treatment ARV Prophylaxis 28 wks Basic Care Package (BCP) (Male ) Early Infant Male Circumcision* Female Free (Free Male ) Free Female HAART Lubricants (A, B, C, D, E) Male Circumcision* Naloxone Needle & Syringe Nevirapine STI Kit STI Kit (Non Ulcerative) STI Kit (Ulcerative) TB DOTS VCT (Voluntary Counseling and Testing)* Malaria Control Insecticide Treated Net (ITN)* LLIN (Long Lasting Insecticidal Net)* Malaria PPT (ACT) Malaria RDK (Rapid Diagnostic Kit) Retreatment Retreatment IconMaxx* Retreatment KO 123* Retreatment KO 123 bundled with Net* Reproductive Health Clean Delivery Kit (CDK) (Male ) Cycle beads (SDM)* Emergency Contraception Female Free (Free Male ) Free Female Hormonal Implant 3 year* Hormonal Implant 3 year Insertion* Hormonal Implant 5 year* Hormonal Implant 5 year Insertion* Injectable 1 month Injectable 2 month Injectable 3 month Intrauterine Device* Intrauterine Device Insertion* Iron Folic Acid Manual Vacuum Aspiration (MVA) Medication Abortion Misoprostol Multivitamin Oral Contraceptive Vaginal Foaming Tablet Child Survival Deworming Tablet Diarrhea Treatment Kit (DTK) Infant Fortified Food ORS Pneumonia PPT PUR Safe Water Solution Sprinkle Water Treatment Tablet (Chlorine Tab) Zinc * Products & Services with multi year impact Data for hormonal implant insertion, IUD insertion, male circumcision, TB DOTS and VCT come from the Health Services Database. OCTOBER HEALTH IMPACT REPORT EXECUTIVE SUMMARY 12

13 :: Table of Contents I. Summary Tables CYPs, Cases, and Deaths Regional Summary 1 DALYs Report by Region 2 DALYs Report by Health Area 3 DALYs Report by Country 4 Distribution Report by Product 10 II. Regional Performance West and Central Africa 21 East Africa 49 Southern Africa 75 Latin America & Caribbean 97 Asia and Eastern Europe 123 III. Price to Consumer 149 IV. Trade Margin 157 OCTOBER HEALTH IMPACT REPORT

14 Summary Tables by Region, Health Area, Country and Product

15 CYPs, Cases, and Deaths by Region 1/ 10/ HIV & TB Reproductive Health Malaria Control Child Survival Cases STI Deaths IDU Deaths TB Deaths CYP* Maternal Deaths Unintended Pregnancies Malaria Cases Malaria Deaths Diarrhea Cases Diarrhea Deaths Nutrition Deaths Pneumonia Cases Pneumonia Deaths Sum of All Deaths West and Central Africa 47,519 4,309,241 9,049 1,345,372 25,186, , ,960 1, ,147 East Africa 32, ,224,000 3, ,693 15,521, ,673 1,446,322 2,954 2, ,833 Southern Africa 52, ,486,621 2, ,569 2,236,528 24,903 1,207,498 2,650 30,277 Americas , ,636 5, , Asia and Eastern Europe 8, ,780 5,447,427 4, , ,309 3,288 98,597 1, ,302 Total 142, ,780 15,020,688 18,799 3,478,878 43,124, ,530 3,187,469 8, , ,795 * Using USAID CYP conversion factors /15/ 4:56:47PM Page 1 of 1

16 Monthly DALY Report by Region Year: DALY 10/ Percentage Change Percentage of Category Annual DALY Target Percentage of Target Achieved GRAND 1,406,072 10,727,567 17,824,617 66% 19,044,055 94% West and Central Africa 859,090 3,147,569 9,308, % 100 % 8,162, % HIV & TB 169, , ,752 (3)% 10% 1,092,345 84% Reproductive Health 189,966 1,155,153 1,208,143 5% 13% 1,377,659 88% Malaria Control 492, ,530 7,103, % 76% 5,510, % Child Survival 7,454 56,914 76,410 34% 1% 182,468 42% East Africa 262,875 4,648,388 5,052,270 9% 100 % 6,360,110 79% HIV & TB 71, , ,781 0% 17% 1,045,045 84% Reproductive Health 51, , ,906 5% 10% 642,342 78% Malaria Control 122,595 3,144,360 3,488,442 11% 69% 4,202,524 83% Child Survival 17, , ,140 28% 4% 470,199 39% Southern Africa 172,753 1,934,030 2,343,287 21% 100 % 3,168,280 74% HIV & TB 77,812 1,275,456 1,063,514 (17)% 45% 1,739,312 61% Reproductive Health 63, , ,282 (4)% 18% 543,266 77% Malaria Control 16, , , % 33% 795,744 98% Child Survival 15,418 62,986 84,944 35% 4% 89,958 94% Americas 4,622 53,247 50,229 (6)% 100 % 78,066 64% HIV & TB 1,726 18,923 18,349 (3)% 37% 28,190 65% Reproductive Health 2,895 29,830 30,764 3% 61% 40,779 75% Malaria Control ,004% 1% % Child Survival 1 4, (85)% 1% 8,676 8% Asia and Eastern Europe 106, ,334 1,070,126 13% 100 % 1,274,818 84% HIV & TB 17, , ,413 32% 20% 269,682 79% Reproductive Health 78, , ,623 7% 65% 851,788 82% Malaria Control 7,712 69, ,703 49% 10% 77, % Child Survival 2,942 61,186 57,387 (6)% 5% 76,153 75% /15/ 2:08:59PM Page 1 of 1

17 Monthly DALY Report by Health Area Year: DALY 10/ Percentage Change Percentage of Category Annual DALY Target Percentage of Target Achieved GRAND 1,406,072 10,727,567 17,824,617 66% 19,044,055 94% HIV & TB 337,747 3,291,751 3,094,810 (6)% 100% 4,174, % West and Central Africa 169, , ,752 (3)% 30 % 1,092,345 84% East Africa 71, , ,781 0% 28 % 1,045,045 84% Southern Africa 77,812 1,275,456 1,063,514 (17)% 34 % 1,739,312 61% Americas 1,726 18,923 18,349 (3)% 1 % 28,190 65% Asia and Eastern Europe 17, , ,413 32% 7 % 269,682 79% Reproductive Health 385,766 2,754,838 2,856,719 4% 100% 3,455, % West and Central Africa 189,966 1,155,153 1,208,143 5% 42 % 1,377,659 88% East Africa 51, , ,906 5% 18 % 642,342 78% Southern Africa 63, , ,282 (4)% 15 % 543,266 77% Americas 2,895 29,830 30,764 3% 1 % 40,779 75% Asia and Eastern Europe 78, , ,623 7% 24 % 851,788 82% Malaria Control 638,963 4,352,625 11,471, % 100% 10,586, % West and Central Africa 492, ,530 7,103, % 62 % 5,510, % East Africa 122,595 3,144,360 3,488,442 11% 30 % 4,202,524 83% Southern Africa 16, , , % 7 % 795,744 98% Americas ,004% 0 % % Asia and Eastern Europe 7,712 69, ,703 49% 1 % 77, % Child Survival 43, , ,568 22% 100% 827, % West and Central Africa 7,454 56,914 76,410 34% 19 % 182,468 42% East Africa 17, , ,140 28% 45 % 470,199 39% Southern Africa 15,418 62,986 84,944 35% 21 % 89,958 94% Americas 1 4, (85)% 0 % 8,676 8% Asia and Eastern Europe 2,942 61,186 57,387 (6)% 14 % 76,153 75% /15/ 1:48:29PM Page 1 of 1

18 Monthly DALY Report by Country Year: DALY 10/ Percentage Change Percentage of Category Annual DALY Target Percentage of Target Achieved GRAND 1,406,072 10,727,567 17,824,617 66% 19,044,055 94% West and Central Africa 859,090 3,147,569 9,308, % 100 % 8,162, % Benin 4,166 98,391 92,156 (6)% 1% 102,615 90% HIV & TB ,052 25,536 34% 0% 28, % Reproductive Health 2,654 32,433 40,296 24% 0% 38, % Malaria Control 96 11,877 10,830 (9)% 0% 7, % Child Survival ,029 15,493 (56)% 0% 28, % Burkina Faso 7,556 75,566 78,023 3 % 1% 104,904 74% HIV & TB 3,663 37,102 37,265 0% 0% 51, % Reproductive Health 3,893 38,464 40,758 6% 0% 53, % C.A.R. 5,234 25,009 23,855 (5)% % 76,568 31% HIV & TB 3,047 14,558 13,861 (5)% 0% 25, % Reproductive Health 2,187 10,450 9,994 (4)% 0% 18, % Malaria Control 0% 0% 33,469 0 % Cameroon 412, , , % 6% 1,015,811 52% HIV & TB 9,059 63,504 65,009 2% 1% 114, % Reproductive Health 7,634 41,221 49,448 20% 1% 78, % Malaria Control 395,641 17, ,759 2,302% 4% 815, % Child Survival 614 1,951 3,207 64% 0% 6, % CongoKinshasa 20, ,869 2,987, % 32% 3,037,616 98% HIV & TB 8, , ,686 (27)% 1% 111, % Reproductive Health 7, , ,392 (14)% 1% 121, % Malaria Control 2,512 36,152 2,693,682 7,351% 29% 2,700, % Child Survival 2,624 2,196 24,890 1,033% 0% 104, % Cote d'ivoire 631 8,456 1,776,835 20,912 % 19% 779, % HIV & TB 97 1, (69)% 0% 4, % Reproductive Health (72)% 0% % Malaria Control 657 1,763, ,413% 19% 770, % Child Survival 499 5,006 12, % 0% 4, % Cote d'ivoire (AIMAS) 8, , ,394 (11)% 1% 131, % HIV & TB 4,496 81,983 66,648 (19)% 1% 67, % Reproductive Health 4,221 69,509 68,746 (1)% 1% 63, % Guinea 2,225 50,777 39,759 (22)% % 76,352 52% HIV & TB ,393 13,036 (15)% 0% 21, % Reproductive Health 1,164 31,869 23,345 (27)% 0% 49, % Child Survival 137 3,515 3,377 (4)% 0% 5, % Liberia 477 1,919 4, % % 6,870 67% HIV & TB , % 0% 1, % Reproductive Health , % 0% 1, % Child Survival 306 1,472 1,770 20% 0% 3, % Mali 21, ,709 1,188, % 13% 1,256,905 95% HIV & TB 1,980 18,983 22,754 20% 0% 28, % Reproductive Health 9,725 86, ,325 20% 1% 121, % Malaria Control 9, ,634 1,059, % 11% 1,105, % Child Survival , % 0% 1, % Nigeria 370,637 1,771,492 2,400, % 26% 1,489, % /15/ 2:12:30PM Page 1 of 6 4

19 Monthly DALY Report by Country Year: DALY 10/ Percentage Change Percentage of Category Annual DALY Target Percentage of Target Achieved HIV & TB 135, , ,478 5% 6% 606, % Reproductive Health 148, , ,994 7% 7% 782, % Malaria Control 84, ,050 1,164,151 91% 13% 72,626 1,603 % Child Survival 2,287 6,748 12,122 80% 0% 27, % Togo 5,100 57,195 54,387 (5)% 1% 84,409 64% HIV & TB 1,883 20,407 18,477 (9)% 0% 31, % Reproductive Health 3,084 31,647 33,213 5% 0% 48, % Malaria Control 134 5,142 2,697 (48)% 0% 4, % East Africa 262,875 4,648,388 5,052,270 9% 100 % 6,360,110 79% Angola 1, , , % 9% 193, % HIV & TB ,383 23,103 41% 0% 31, % Reproductive Health ,586 24,995 42% 0% 34, % Malaria Control 215, ,536 76% 8% 120, % Child Survival 4,760 4,997 5% 0% 6, % Burundi 1, , , % 16% 701, % HIV & TB 816 5,066 11, % 0% 10, % Reproductive Health 475 2,899 6, % 0% 6, % Malaria Control 171, , % 15% 682, % Child Survival 3, (81)% 0% 1, % Ethiopia 23,116 66,161 83, % 2% 187,015 44% HIV & TB 11,365 24,142 51, % 1% 101, % Reproductive Health 7,812 17,911 11,941 (33)% 0% 40, % Malaria Control 1,845 1,166 2, % 0% 12, % Child Survival 2,093 22,941 16,838 (27)% 0% 32, % Kenya 59,697 1,068,454 1,557, % 31% 1,525, % HIV & TB 13, , ,916 15% 6% 271, % Reproductive Health 15, , ,777 64% 4% 143, % Malaria Control 28, ,991 1,066,636 56% 21% 1,091, % Child Survival 2,051 14,653 14,150 (3)% 0% 18, % Malawi 62, , , % 13% 702,168 91% HIV & TB 2,967 31,490 24,931 (21)% 0% 37, % Reproductive Health 1,363 12,374 13,406 8% 0% 15, % Malaria Control 47, , , % 10% 282, % Child Survival 11,069 53, , % 2% 366, % Mozambique 39, , , % 11% 481, % HIV & TB 6, , ,090 (39)% 2% 138, % Reproductive Health 2,197 49,073 27,258 (44)% 1% 50, % Malaria Control 30, , , % 9% 279, % Child Survival 878 7,797 9,267 19% 0% 13, % Rwanda 5, ,521 80,382 (76)% 2% 202,830 40% HIV & TB 3,359 39,635 32,932 (17)% 1% 56, % Reproductive Health 2,163 24,530 21,366 (13)% 0% 35, % Malaria Control 263,783 14,961 (94)% 0% 98, % Child Survival 95 10,573 11,123 5% 0% 12, % Somaliland 328 7,225 4,852 (33)% % 5,673 86% Reproductive Health 39 1, (22)% 0% 2, % Child Survival 289 6,170 4,027 (35)% 0% 3, % /15/ 2:12:38PM Page 2 of 6 5

20 Monthly DALY Report by Country Year: DALY 10/ Percentage Change Percentage of Category Annual DALY Target Percentage of Target Achieved Sudan 15,957 1,219, ,693 (75)% 6% 1,638,818 19% HIV & TB 728 5,539 4,237 (24)% 0% 4, % Reproductive Health 316 2,525 1,895 (25)% 0% 2, % Malaria Control 14,664 1,204, ,597 (75)% 6% 1,629, % Child Survival 250 7,311 1,964 (73)% 0% 1, % Tanzania 34, , ,595 (44)% 8% 583,229 68% HIV & TB 20, , ,453 (22)% 4% 314, % Reproductive Health 12, , ,764 (18)% 3% 255, % Malaria Control ,825 11,826 (95)% 0% 5, % Child Survival 963 6,572 6,552 0% 0% 7, % Uganda 18, , , % 4% 138, % HIV & TB 10,375 48, , % 2% 77, % Reproductive Health 7,669 44,617 52,163 17% 1% 56, % Malaria Control ,497 11,262 (78)% 0% 0 % Child Survival 93 5,517 3,371 (39)% 0% 4, % Southern Africa 172,753 1,934,030 2,343,287 21% 100 % 3,168,280 74% Botswana 3,141 31,821 53, % 2% 60,803 87% HIV & TB 2,663 26,826 45,043 68% 2% 51, % Reproductive Health 478 4,995 8,091 62% 0% 9, % Malaria Control (96)% 0% 0 % Lesotho 4,550 59,982 90, % 4% 90,853 99% HIV & TB 3,713 48,864 72,516 48% 3% 76, % Reproductive Health ,118 17,807 60% 1% 14, % Madagascar 58, , , % 11% 280,917 89% HIV & TB 5,061 40,069 43,902 10% 2% 45, % Reproductive Health 44, , ,509 12% 6% 153, % Malaria Control 3,552 15,777 22,042 40% 1% 40, % Child Survival 5,148 32,268 42,040 30% 2% 41, % Namibia 2,188 22,441 12,147 (46)% 1% 26,449 46% HIV & TB 1,646 17,934 8,761 (51)% 0% 20, % Reproductive Health 336 3,669 1,790 (51)% 0% 4, % Malaria Control ,596 90% 0% 2, % Child Survival 0% 0% South Africa 28, , ,095 (36)% 23% 995,578 55% HIV & TB 23, , ,211 (36)% 20% 835, % Reproductive Health 4, ,849 89,884 (37)% 4% 160, % Swaziland 4,155 82,258 49,988 (39)% 2% 87,247 57% HIV & TB 3,917 77,923 45,494 (42)% 2% 81, % Reproductive Health 238 4,319 4,494 4% 0% 5, % Child Survival 17 (100)% 0% 0 % Zambia 38, ,230 1,051, % 45% 1,192,394 88% HIV & TB 16, , ,650 35% 7% 268, % Reproductive Health 7,962 92, ,017 16% 5% 144, % Malaria Control 12, , , % 32% 747, % Child Survival 1,216 23,652 23,258 (2)% 1% 30, % Zimbabwe 33, , ,272 2 % 12% 434,039 66% HIV & TB 20, , ,937 1% 9% 360, % /15/ 2:12:38PM Page 3 of 6 6

21 Monthly DALY Report by Country Year: DALY 10/ Percentage Change Percentage of Category Annual DALY Target Percentage of Target Achieved Reproductive Health 4,216 53,047 46,690 (12)% 2% 51, % Malaria Control 2,377 (100)% 0% 5,156 0 % Child Survival 9,054 7,050 19, % 1% 17, % Americas 4,622 53,247 50,229 (6%) 100 % 78,066 64% Belize % 1% % HIV & TB % 1% % Reproductive Health % 0% % Caribbean % 1% % HIV & TB % 0% % Reproductive Health % 0% % Costa Rica (6)% 1% % HIV & TB (6)% 0% % Reproductive Health (6)% 0% % Dominican Republic 1,208 10,017 9,195 (8)% 18% 13,631 67% HIV & TB 761 6,317 5,799 (8)% 12% 8, % Reproductive Health 445 3,691 3,384 (8)% 7% 5, % Child Survival % 0% % Dominican Republic Panam (48)% % % Child Survival (48)% 0% % El Salvador 558 3,534 3,154 (11)% 6% 3,609 87% HIV & TB 131 1,537 1,209 (21)% 2% 1, % Reproductive Health 427 1,998 1,944 (3)% 4% 2, % Guatemala 1,166 11,353 10,624 (6)% 21% 15,803 67% HIV & TB 269 3,853 3,491 (9)% 7% 5, % Reproductive Health 897 7,500 7,134 (5)% 14% 10, % Haiti ,957 12, % 24% 24,510 49% HIV & TB 195 2,570 3,814 48% 8% 7, % Reproductive Health 190 4,004 7,153 79% 14% 8, % Malaria Control ,004% 1% % Child Survival 4, (86)% 1% 8,563 7 % Honduras 266 4,387 2,905 (34)% 6% 3,864 75% HIV & TB 131 2,209 1,433 (35)% 3% 1, % Reproductive Health 135 2,179 1,472 (32)% 3% 1, % Mexico % % % HIV & TB % 0% % Reproductive Health (17)% 0% % Nicaragua 200 4,986 4,566 (8)% 9% 5,980 76% HIV & TB (19)% 1% % Reproductive Health 169 4,604 4,254 (8)% 8% 5, % Panama 121 1,742 1,867 7 % 4% 2,829 66% HIV & TB 80 1,151 1,233 7% 2% 1, % Reproductive Health % 1% % Paraguay 570 5,111 4,654 (9)% 9% 6,225 75% HIV & TB % 0% % Reproductive Health 547 4,898 4,415 (10)% 9% 5, % Asia and Eastern Europe 106, ,334 1,070,126 13% 100 % 1,274,818 84% /15/ 2:12:38PM Page 4 of 6 7

22 Monthly DALY Report by Country Year: DALY 10/ Percentage Change Percentage of Category Annual DALY Target Percentage of Target Achieved Cambodia 6,804 90,490 86,591 (4)% 8% 114,292 76% HIV & TB ,605 13,242 (3)% 1% 18, % Reproductive Health 5,549 47,749 58,239 22% 5% 63, % Malaria Control 74 26,317 12,589 (52)% 1% 28, % Child Survival 467 2,820 2,520 (11)% 0% 3, % China % % 38 1,576% HIV & TB % 0% 21 1,216 % Reproductive Health % 0% 17 1,958 % Malaria Control 1 9 1,213% 0% 0 % India 47, , , % 42% 547,294 82% HIV & TB 6,367 55,019 89,253 62% 8% 114, % Reproductive Health 41, , ,263 26% 31% 396, % Child Survival 74 28,490 21,811 (23)% 2% 36, % Kazakhstan 400 2,304 1,519 (34)% % 3,745 41% HIV & TB (95)% 0% % Reproductive Health 399 1,740 1,490 (14)% 0% 3, % Kyrgyzstan (67)% % % HIV & TB % 0% % Reproductive Health (72)% 0% % Laos 642 3,409 7, % 1% 4, % HIV & TB ,141 43% 0% % Reproductive Health 543 2,511 6, % 1% 3, % Malaria Control 101 (100)% 0% 0 % Myanmar 21, , , % 20% 211, % HIV & TB 8,141 66,424 69,712 5% 7% 94, % Reproductive Health 3,499 29,794 29,542 (1)% 3% 36, % Malaria Control 7,638 42,383 90, % 8% 47, % Child Survival 2,347 23,999 27,015 13% 3% 32, % Nepal 1,300 14,049 14,616 4 % 1% 26,157 56% HIV & TB 0% 0% 0 % Reproductive Health 1,280 11,991 13,287 11% 1% 22, % Malaria Control 332 (100)% 0% 1,134 0 % Child Survival 20 1,726 1,329 (23)% 0% 2, % Pakistan 26, , ,582 (12)% 25% 333,767 79% HIV & TB 1,349 11,756 17,372 48% 2% 17, % Reproductive Health 25, , ,542 (15)% 23% 315, % Child Survival 34 4,129 4,668 13% 0% % Papua New Guinea ,630 1,237 % 1% 9, % HIV & TB ,681 1,238% 1% 6, % Reproductive Health ,949 1,235% 0% 3, % Romania 171 1,948 4, % % 4, % HIV & TB 128 1,466 3, % 0% 3, % Reproductive Health , % 0% 1, % Russia 160 2,932 2,655 (9)% % 1, % HIV & TB 160 2,872 2,608 (9)% 0% 1, % Reproductive Health (21)% 0% % /15/ 2:12:38PM Page 5 of 6 8

23 Monthly DALY Report by Country Year: DALY 10/ Percentage Change Percentage of Category Annual DALY Target Percentage of Target Achieved Tajikistan , % % 1,259 90% HIV & TB 134 0% 0% % Reproductive Health ,002 70% 0% 1, % Thailand 106 1,339 2, % % 2,416 87% HIV & TB 101 1,310 2,020 54% 0% 2, % Reproductive Health % 0% % Vietnam ,567 9,676 (8)% 1% 14,112 69% HIV & TB 588 6,874 6,245 (9)% 1% 9, % Reproductive Health 327 3,671 3,388 (8)% 0% 4, % Child Survival % 0% % /15/ 2:12:38PM Page 6 of 6 9

24 Monthly Distribution by Product Year: 10/ % Antiretroviral Treatment 4,200 3,600 33,000 10,800 4, % 10,260 43,260 Asia and Eastern Europe 4,200 3,600 33,000 10,800 4, % 10,260 43,260 ARV Propylaxis 28 wks (Mother and Ba 282 % 282 1,099 Asia and Eastern Europe 282 % 282 1,099 ARV Propylaxis 28 wks (Mother Only) 88 % Asia and Eastern Europe 88 % Basic Care Package 912,888 1,510,777 7,773, , ,597 1,044% 757,187 9,096, ,043 West and Central Africa % East Africa 912,888 1,510,777 7,773, , ,597 1,044% 757,187 9,096, ,043 Clean Delivery Kit 4,921 5,110 50,028 72,500 52,106 (4)% 63,191 1,331,153 2,042 West and Central Africa 291 2,230 14,720 22,500 19,699 (25)% 22, , East Africa 3,886 2,138 22,933 50,000 18,177 26% 20, , Asia and Eastern Europe ,375 14,230 (13)% 19, , ,917,862 82,564, ,553,167 1,083,864, ,612,099 7% 1,008,566,488 15,607,345,772 3,436,070 West and Central Africa 53,221,307 19,613, ,341, ,356, ,657,369 (1)% 353,983,082 4,034,173,645 1,583,508 East Africa 11,550,169 13,525, ,263, ,308, ,150,473 (19)% 170,751,809 2,082,724, ,914 Southern Africa 6,306,334 11,102, ,959, ,714, ,095,755 7% 128,047,703 1,223,192, ,028 Americas 3,474,957 3,613,887 34,705,451 52,025,372 36,944,729 (6)% 44,328, ,148,685 32,514 Other Africa % 14,310,880 Asia and Eastern Europe 23,365,095 34,709, ,283, ,459, ,763,773 35% 311,455,847 7,332,795, ,106 Deworming Tablets 40, ,935 (85)% 494,271 1,095,308 East Africa 40, ,933 (85)% 492, ,174 Southern Africa 2,002 (100)% 2, ,134 Diarrhea Treatment Kit 91, ,369 1,041,105 1,937,500 1,227,913 (15)% 1,489,792 3,615,563 42,798 West and Central Africa 25,466 31, ,071 1,028, ,241 (29)% 508,016 1,346,051 15,347 East Africa 4,451 2,998 15, ,030 (91)% 173, , Southern Africa 14,754 12, , , ,762 1% 156, ,776 5,470 Asia and Eastern Europe 46,774 59, , , ,880 16% 652,109 1,627,736 21, /15/ 2:14:56PM 10 Page 1 of 10

25 Monthly Distribution by Product Year: 10/ % Early Infant MC (HIVNegative) % Southern Africa % Early Infant MC (HIVUnknown) % Southern Africa % Emergency Contraception 528, ,747 2,640,915 3,172,496 2,101,856 26% 2,973,322 17,675,911 20,086 West and Central Africa 210, , ,941 1,430, ,380 (4)% 1,167,930 7,075,757 10,228 East Africa 165,319 63, ,369 % 369,090 3,108 Southern Africa 2,880 5,581 52,300 45,000 46,115 13% 57, , Americas 19,358 16, , , ,640 22% 170,657 2,458, Asia and Eastern Europe 130, ,766 1,167,351 1,509, ,721 19% 1,576,915 7,480,981 6,097 Female 1,454,428 (833,694) 6,487,467 6,222,543 4,577,214 42% 5,968,243 40,941,109 37,753 West and Central Africa 1,227,901 (1,237,123) 3,676,673 3,134,822 1,727, % 2,404,640 9,866,667 21,375 East Africa 17,222 72, , , ,813 (13)% 723,353 3,884,681 3,128 Southern Africa 150, ,367 1,873,062 1,881,000 1,939,967 (3)% 2,358,361 21,599,098 12,533 Americas 4,200 3,973 65,808 57,000 30, % 34,034 3,619, Asia and Eastern Europe 54,785 53, , , ,932 25% 447,855 1,971, Free 17,686,396 16,049, ,861, ,645, ,002,652 (9)% 258,313,784 1,025,020, ,280 West and Central Africa 1,799,954 1,590,943 11,349,843 3,102,080 13,856,048 (18)% 17,066,695 73,172,334 38,604 East Africa 8,402,722 5,399,052 85,652,120 55,050,000 38,083, % 53,412, ,937, ,773 Southern Africa 7,397,046 8,776,249 87,626, ,160, ,908,519 (43)% 178,612, ,884, ,216 Americas 12,578 22, , ,000 2,729,826 (84)% 2,926,790 6,230, Asia and Eastern Europe 74, ,580 9,783,229 9,724,646 5,424,601 80% 6,295,601 30,794,908 11,441 Free Female 69, , ,130 1,003, ,737 (24)% 860,532 2,422,839 2,428 West and Central Africa % 3,600 East Africa 42, , , , ,901 (7)% 642,123 1,266,759 2,240 Southern Africa 26,500 1,928 41, , ,321 (69)% 137, , Americas ,757 59,217 41,983 (82)% 45,456 70,845 6 Asia and Eastern Europe ,490 21,114 33,532 (54)% 35,332 96, /15/ 2:15:05PM 11 Page 2 of 10

26 Monthly Distribution by Product Year: 10/ % HAART (Mother and Baby) 200 % Asia and Eastern Europe 200 % HAART (Mother Only) 51 % Asia and Eastern Europe 51 % Implant 3 Distribution 172 (448) (2,750) 4,000 2,884 (195)% 3,489 28,914 (1,804) West and Central Africa (577) (3,328) (319) % (319) (3,647) (2,005) East Africa (578) 2,739 (121)% 2,956 6,059 (296) Southern Africa ,180 4, % 781 3, Americas (24) (113) (19) % (35) (148) (9) Asia and Eastern Europe % , Implant 3 Insertion ,985 3, % 3,462 11,447 4,157 West and Central Africa 577 3, % 595 4,572 2,424 East Africa 162 1, ,843% 7 1, Southern Africa ,578 1,586 (1)% 1,914 3, Americas % Asia and Eastern Europe (12)% 889 1, Implant 5 Distribution 761 6,549 28, ,747 31,156 (9)% 31, ,451 15,879 West and Central Africa 3,012 2,447 19,825 41,056 11,029 80% 9,515 51,302 14,213 East Africa (464) 141 (473) 4, (187)% 1,219 13,499 (88) Southern Africa (1,989) 3,310 5,554 48,200 19,084 (71)% 19,413 68, Americas (11) (40) % (31) 7, Asia and Eastern Europe ,022 12, % 1,150 10, Implant 5 Insertion 10,851 9,221 79,272 75,783 5% 90, ,415 51,884 West and Central Africa 3,677 2,893 28,148 36,275 (22)% 43,282 71,430 20,047 East Africa 4,477 3,533 21,716 10, % 13,287 35,003 13,183 Southern Africa 2,299 2,524 26,389 23,824 11% 28,049 54,438 17,876 Americas ,237 (78)% 2,412 2, Asia and Eastern Europe ,522 2,609 (3)% 3,113 5, /15/ 2:15:05PM 12 Page 3 of 10

27 Monthly Distribution by Product Year: 10/ % Infant Fortified Food % 91,859 Asia and Eastern Europe % 91,859 Injectable 1 15,927 10, , , ,105 (50)% 460,517 2,323,267 1,929 West and Central Africa 3, ,151 70,000 39,007 (56)% 41, , Americas ,198 33,800 58,080 (41)% 67, , Asia and Eastern Europe 12,617 9, , , ,018 (51)% 352,020 2,059,992 1,415 Injectable 2 226,500 99,590 1,320,039 1,768,804 1,411,527 (6)% 1,663,617 13,607,806 50,621 West and Central Africa 164,700 59, ,244 1,200, ,617 (8)% 1,127,847 8,972,046 41,405 Asia and Eastern Europe 61,800 40, , , ,910 (3)% 535,770 4,635,760 9,216 Injectable 3 977, ,859 5,181,747 5,639,279 4,075,204 27% 5,029,580 43,652, ,800 West and Central Africa 200, ,235 1,783,046 2,050,277 1,126,379 58% 1,681,037 14,449, ,551 East Africa 25,710 66, , , ,611 17% 562,625 8,353,525 27,689 Southern Africa 561,800 56,611 1,205,334 1,082,000 1,016,403 19% 1,070,917 7,680,081 63,266 Americas 3,200 18, , , ,666 22% 169,185 2,532,377 3,476 Asia and Eastern Europe 185, ,263 1,507,687 1,638,072 1,354,145 11% 1,545,816 10,637,060 34,818 Iron Folic Acid Tablet 299, ,200 3,035,400 2,172,400 1,728,000 76% 2,026,200 44,006,610 50,149 Asia and Eastern Europe 299, ,200 3,035,400 2,172,400 1,728,000 76% 2,026,200 44,006,610 50,149 ITN 41,286 40, ,940 (83)% 311,755 19,397,605 8,282 West and Central Africa % 891,146 East Africa 41,286 40, ,940 (83)% 311,755 18,226,857 8,282 Southern Africa % 249,314 Americas % 30,288 IUD Distribution 69,981 45, , , ,019 (7)% 613,595 4,200, ,787 West and Central Africa 8,949 5,563 71,743 25,449 56,580 27% 73,637 1,188,489 62,067 East Africa 1,617 1,597 18,471 55,760 9,739 90% 11,650 75,649 15,179 Southern Africa 83 (319) (4,248) 40,000 (2,211) % ,969 (3,334) Americas 4,079 6,316 25,733 45,000 9, % 12, ,027 3,591 Asia and Eastern Europe 55,253 32, , , ,549 (17)% 515,675 2,733, , /15/ 2:15:05PM 13 Page 4 of 10